MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Spinocerebellar ataxias(SCA)"

  • 2024 International Congress

    Spinocerebellar Ataxia 34: ELOVL4 Recurrent Mutation in a Different Family

    K. Makhoul, R. Ramdhani (Little Neck, USA)

    Objective: We present a rare case of Spinocerebellar Ataxia 34 (SCA 34) in a Vietnamese patient. Background: SCA 34 is a subtype of Spinocerebellar Ataxia…
  • 2024 International Congress

    Transcranial Direct Current Stimulation and Neurofunctional Physical Therapy Improves Motor and Cognitive Symptoms in a Patient with Type 1 Spinocerebellar Ataxia – A Case Report

    C. Bedeschi, P. Junior (Barueri, Brazil)

    Objective: The aim of this research was to develop and verify the effects of a Non-Invasive Neuromodulation protocol associated with Neurofunctional Physiotherapy on motor functions,…
  • 2024 International Congress

    White Matter Tractography in Spinocerebellar Ataxia type 1 and 2 in comparison with Healthy Controls

    P. Pankaj, A. Srivastava, M. Kumar, S. Kumaran, A. Garg, R. Agarwal, A. Nehra (New Delhi, India)

    Objective: To assess and quantify microstructural white matter atrophy in brain of spinocerebellar ataxia (SCA) types SCA1 and SCA2 patients in comparison with healthy subjects.…
  • 2024 International Congress

    Non Classified Spinocerebellar Ataxia-like Syndrome due to GYG-1 gene mutation with TPM3, GEMIN5 and DES mutations in a Peruvian family

    W. Trillo Alvarez, A. Escalante Mercado, D. Hito Cano, L. Delgado Villanueva, K. Choque Pereyra, E. Carrillo Monteagudo, P. Gonzales Romero (Arequipa, Peru)

    Objective: To report a GYG1 mutation in a Peruvian family presenting as a non classified Spinocerebellar Ataxia (SCA) with added GEMIN5, DES and TPM3 mutations.…
  • 2024 International Congress

    Case Report of Spinocerebellar Ataxia 13 Presenting with Pure Cerebellar Ataxia

    S. Park (Daejeon, Republic of Korea)

    Objective: We report the spinocerebellar ataxia 13 (SCA13) patient who demonstrated childhood-onset pure cerebellar ataxia. Background: SCA13 is a rare cause of autosomal-dominant cerebellar ataxia,…
  • 2024 International Congress

    Tremulous Machado-Joseph Disease

    V. Procaci, L. de Farias, S. da Costa, O. Barsottini, J. Pedroso (Sao Paulo, Brazil)

    Objective: To describe a case of spinocerebellar ataxia type 3 (SCA3) presenting with tremor. Background: Tremor is not a frequent manifestation in SCA3, especially as…
  • 2024 International Congress

    Fixel Analysis of Diffusion Imaging in Cerebellar Tracts as a Quantitative Marker of Disease Progression in Spinocerebellar Ataxia

    D. Arpin, S. Subramony, D. Vaillancourt, M. Burns (Gainesville, USA)

    Objective: This study aimed to identify white matter changes in the brain of presymptomatic and early-stage SCA1 and SCA3 mutation carriers using fixel-based analysis of…
  • 2024 International Congress

    Spinocerebellar ataxia type 2 (SCA2) and Seizures: Is There a Correlation?

    P. Bhatia, S. Kaur (Phoenix, USA)

    Objective: We describe 3 patients of SCA2 with seizures, a rare phenomenology. Background: Spinocerebellar ataxia (SCA) is a heterogenous group of autosomal dominant neurodegenerative ataxic…
  • 2024 International Congress

    4-Aminopyridine improves downbeat nystagmus in SCA27b: A case report

    S. Coulette, M. Philibert, JM. Trocello, B. Gaymard, C. Desjardins (Paris, France)

    Objective: To assess objective clinical improvement in video-oculography in a patient with SCA27b on 4-aminopyridine (4-AP) treatment. Background: Spinocerebellar ataxia 27b (SCA27b; MIM 620174) is…
  • 2024 International Congress

    Mixed Cerebellar Ataxia in a Patient with a Novel FAT2 Gene Variant Associated with SCA45

    A. Richmond, M. Nashatizadeh, R. Townley (Columbia, USA)

    Objective: We describe a patient with late-onset ataxia, cognitive impairment, and parkinsonism with a novel missense variant in FAT2, a gene implicated in spinocerebellar ataxia…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • …
  • 14
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley